Norris Financial Group, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 2129318 GREENVILLE, SC

Position in CRSP

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$494,186

+$148,971 QoQ

Shares Held

9,061

+24.9% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#221

of 521 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Norris Financial Group, LLC holds $6,694,632 across 4 Biotechnology names. CRSP ranks #2 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AUPH	Aurinia Pharmaceuticals Inc.	342,331	$5,809,357
2	CRSP	CRISPR Therapeutics AG This page	9,061	$494,186
3	INCY	Incyte Corp	2,359	$267,416
4	IBRX	ImmunityBio, Inc.	14,126	$123,673

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$494,186	9,061	+24.9%	Shares	Sole	2026-08-05
2026-03-31	$345,215	7,257	-7.5%	Shares	Sole	2026-05-20
2025-12-31	$411,234	7,842	-1.4%	Shares	Sole	2026-05-20
2025-09-30	$515,498	7,954	-18.2%	Shares	Sole	2026-05-20
2025-06-30	$473,024	9,725	+0.5%	Shares	Sole	2026-05-20
2025-03-31	$329,308	9,677	+47.4%	Shares	Sole	2026-05-20
2024-12-31	$258,359	6,564	-36.6%	Shares	Sole	2026-05-20
2024-09-30	$486,430	10,354	+2.4%	Shares	Sole	2026-05-20
2024-06-30	$546,257	10,114	-19.5%	Shares	Sole	2026-05-20
2024-03-31	$856,021	12,559	-15.5%	Shares	Sole	2026-05-20
2023-12-31	$930,674	14,867	+2.9%	Shares	Sole	2026-05-20
2023-09-30	$655,885	14,450	+19.5%	Shares	Sole	2026-05-20
2023-06-30	$678,957	12,094	+245.3%	Shares	Sole	2026-05-20
2022-03-31	$219,820	3,502	—	Shares	Sole	2026-05-20
No filing history on record for this holder in this stock.